Aptevo Therapeutics (APVO) Earnings Date & Reports

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

APVO is expected to report earnings to fall 90.09% to -43 cents per share on May 09

Aptevo Therapeutics APVO Stock Earnings Reports

Q1'24

Est.

$-0.44

Q1'25

Missed

by $4.11

Q4'23

Missed

by $11.52

Q3'23

Missed

by $21.36

Q2'23

Missed

by $53.00

The last earnings report on May 15 showed earnings per share of -438 cents, missing the estimate of -28 cents. With 39.70K shares outstanding, the current market capitalization sits at 3.23M.

View a ticker or compare two or three

Compare

APVO